Interviews

Proven medical device and health technology experts will show you how to improve your sales & marketing efforts, enhance your regulatory submissions, raise venture capital, and much more.

Latest

Check out the most recent interviews with world-class medical device and health technology founders and CEOs.

Go Premium
Premium

How to Compete with Industry Goliaths

Interview with Butterfly CEO Joe DeVivo

Joe DeVivo, President and CEO of Butterfly Network, is a medtech veteran with extensive leadership experience at both startups and industry giants. Butterfly is developing hand-held ultrasound devices that make medical imaging easier, cheaper, and more widely accessible. In this interview, Joe shares insights on why a lean start in commercialization is better than a high-burn, high-risk approach, the difference between your company being sold and being purchased, and best practices for managing M&A transactions.

Premium

How to Outpace Your Competition

Interview with Contraline CEO Kevin Eisenfrats

At Contraline, Kevin Eisenfrats and his team are working on a novel long-lasting, reversible male contraceptive. In this interview, Kevin offers insights on how to move swiftly through clinical trials, community-building in medtech, creative fundraising efforts, and the importance of executing thorough scientific and market research.

Premium

Two Important Customers — FDA and CMS

Interview with Procyrion CEO Dr. Eric Fain

After graduating from medical school, Dr. Eric Fain intended to take year before his internship to work at a startup company. But then, he discovered his passion for medtech. Eric has since held key roles throughout the industry, spanning clinical, regulatory, R&D, sales, and marketing for both startups and major players like St. Jude Medical and Abbott. Today, as CEO and President of Procyrion, he's leading the development of an advanced percutaneous mechanical circulatory support device. In this interview, Eric shares his expertise in managing startup finances, attracting investors through strategic planning, drawing up clear clinical roadmaps, and engaging with payers to catalyze commercialization.

Premium

Balancing the Clinical-Commercial Tightrope

Interview with Mercator MedSystems CEO Trent Reutiman

Trent Reutiman has 25 years of leadership experience in medtech with a particular focus on minimally invasive interventional therapies. As the CEO of Mercator, Trent and his team have developed microinfusion devices with the unique ability to locally and directly deliver targeted therapeutics during catheter-based interventions where mechanical therapy isn’t sufficient. In this interview, Trent talks about the importance of generating data, how to balance commercial efforts with clinical initiatives, and why meticulous management is critical for successful commercialization.

Premium

Don’t Build A Unicorn, Build A Useful Zebra

Interview with DeepLook CEO Marissa Fayer

Marissa Fayer, with over two decades of experience in the medtech sector, is the CEO of DeepLook Medical, developers of AI-powered diagnostic tools that help radiologists detect cancerous lesions in dense tissue. In this interview, Marissa talks about the basics of product development, how to build iteratively, tips on identifying ideal regulatory pathways, and how she picks her advisors and board members.

Premium

Managing to a Successful Acquisition

Interview with LimFlow CEO Dan Rose

Dan Rose’s career in medtech features pivotal roles at Direct Flow, Sequana Medical, and Medtronic, culminating in his position as CEO of LimFlow, which recently exited to Inari Medical. In this interview, Dan shares his extensive wisdom on M&A transactions, engaging with investors while maintaining business autonomy, the importance of developing with the ‘average user’ in mind, and the significance of early dialogue with regulatory bodies.

Premium

Get exclusive benefits like full access to the entire archive of Medsider interviews and every Medsider Mentors volume.

Go Premium
Premium

How to Secure Widespread Adoption of Novel Technology

Interview with Magnolia Medical CEO Greg Bullington

Greg Bullington, co-founder and CEO of Magnolia Medical, offers firsthand insights on establishing a new standard of care with Steripath, a device designed to enhance sepsis testing accuracy by reducing blood culture contamination. In this interview, he talks about the pivotal role of robust clinical data, why Magnolia is still running studies even after proving their device’s efficacy, and how to use the results to successfully convince different entities such as FDA and other government bodies in public health.

Premium

How to Get Users to Fall in Love with Your Product

Interview with SafKan Health CEO Sahil Diwan

Sahil Diwan brings a youthful, creative energy to medtech entrepreneurship. His company, SafKan Health, is automating ear wax removal, easing the burden on both patients and physicians. In this interview, we talk about consumer-driven medtech, the power of design, garnering experience from real-world data, focusing on building the business before fundraising, and how OtoSet went viral on social media.

Premium

Winning Together in Medtech

Interview with Orchestra BioMed CEO David Hochman

David Hochman, the maestro behind Orchestra BioMed, shares his journey from conceiving the idea of the company to accelerating high-impact technologies through risk-reward-sharing partnerships with leading medical device companies. Discover his take on driving successful collaborations, operational excellence in R&D, and the importance of a long-term strategy for sustainable industry innovation through aligned incentives.

Premium

From Nurse to Medical Device Entrepreneur

Interview with Swiftsure CEO Deanne McCarthy

Deanne McCarthy’s journey from bedside nursing to entrepreneurship is a compelling story of determination, curiosity, and building vital networks. In this interview, we explore the invaluable role of mentors and connections, Deanne’s insights on accelerator programs, and how her initial lack of startup experience gave her the tenacity to seek out and validate collaborative partners.

Premium

Connecting the Dots Between Medtech and AI

Interview with Sonio CEO Cecile Brosset

In this interview, we talk to Cecile Brosset Dubois about her transition from renowned consulting firms like Bain & Company to leading her own medtech startup, Sonio, which focuses on enhancing obstetric ultrasound with AI. We touch on her strategic approach to product development, the importance of an in-house regulatory team, her drive for meaningful work, and effective tactics for fundraising.

Premium

Rising to the PMA Challenge as a First-Time Founder

Interview with Corveus CEO Tyler Melton

In this interview, Tyler Melton, co-founder and CEO of Corveus Medical, outlines his approach to strategic innovation in medtech. Tyler shares how using off-the-shelf products for early prototypes saved him both time and money and how accelerator programs provided the networking boost his startup needed to tackle the demanding PMA regulatory pathway.

Premium

A Self-Starter’s Guide to Medtech

Interview with Liberate Medical CEO Angus McLachlan

Co-founded by the ingenious Angus McLachlan, Liberate Medical is developing a breakthrough device that synchronizes with a patient's breathing pattern, significantly reducing atrophy of the respiratory muscles for those on mechanical ventilation. In this interview, we talk about Angus’s do-it-yourself philosophy, how a deep understanding of the technology you’re developing gives you leverage across multiple functions, and the nuances of pitching to investors.

Premium

Ancient Wisdom Meets Modern Medtech

Interview with Fisher Wallace CEO Kelly Roman

Kelly Roman, co-founder and CEO of Fisher Wallace, shares his career leap from literature and marketing to pioneering a novel approach to the treatment of mental health. Kelly and his team at Fisher Wallace are combining deep-rooted strategic insights with advanced technological innovation to revolutionize mental health with a wearable brain stimulation device. In this interview, we delve into what Kelly's learned on his journey, touching on the value of unconventional thinking, the importance of making mental health treatments more accessible and less stigmatized, and the potential of decentralized clinical trials.